Search Results

Press Releases

Strategic partnership between Spanios and GlioGuard to accelerate drug treatments for Glioblastoma (GBM)

April 1, 2025

·

3 min read

Business

Accelerated Biosciences and Spanios Partner to Advance Therapeutic Design Across Solid Tumor Cancers

Spanios today announced a partnership with Accelerated Biosciences, a company that licenses its commercial-grade human trophoblast stem cell (hTSC) platform for drug discovery, therapeutic development, biomanufacturing, and toxicology testing.

May 16, 2024

·

3 min read

Business

Rare Cancer Research Foundation (RCRF) and Spanios Forge Strategic Partnership to Accelerate Rare Cancer Research

The Rare Cancer Research Foundation is proud to announce an exciting collaboration with Spanios aimed at propelling the discovery and validation of groundbreaking therapeutic options for rare cancers.

April 4, 2024

·

3 min read

Business

Unravel Biosciences Partners with Spanios to Discover Therapeutic Targets for Rare Cancer

Unravel Biosciences, Inc. today announced a partnership with Spanios (“Spanios”), a precision oncology company facilitating effective treatments for patients with rare and other solid cancers.

November 8, 2022

·

3 min read

Press Releases

Evaluation of SON-1010 Using a Patient-Derived Tumoroid Platform to Support an Ongoing Phase 1 Study in Patients with Sarcoma

October 16, 2025

·

3 min read

Spanios